Contineum Therapeutics In... (CTNM)

AI Score

Unlock

4.59

0.21 (4.79%)

At close: Apr 17, 2025, 3:59 PM

4.62

0.54%

After-hours: Apr 17, 2025, 04:05 PM EDT

Contineum Therapeutics Class A Common Stock Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for CTNM stock have an median target of 25, with a low estimate of 16 and a high estimate of 31. The median target predicts an increase of 444.66% from the current stock price of 4.59.

Target	Low	Average	Median	High
Price	$16	$24.8	$25	$31
Change	248.58%	440.31%	444.66%	575.38%

Latest Analyst Insight Report

RBC Capital maintains an Outperform rating for Con... Unlock content with Pro Subscription

Updated Jan 09, 2025

Rating	Apr 24	Aug 24	Oct 24	Nov 24	Jan 25	Mar 25
Strong Buy	0	0	0	0	0	0
Buy	3	1	1	1	1	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	1	1	1	1	2

Financial Forecast this Year

Revenue This Year

from 0

Revenue Next Year

from 6M

-100%

from 6M

EPS This Year

-2.23

from -2.18

-2.3%

from -2.18

EPS Next Year

-2.9

from -2.23

-30%

from -2.23